Peer Review History
| Original SubmissionAugust 15, 2025 |
|---|
|
PONE-D-25-44019Validating self-reported exclusive breastfeeding in Eswatini using stable isotope techniquesPLOS One Dear Dr. Simelane, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Feb 16 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Jennifer Yourkavitch Academic Editor PLOS One Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. You have indicated that data is available from “ehhrrbeswatini@gmail.com.” Please can we ask you to provide us with a general contact email address for the data requests, so readers can request access in perpetuity. If a general email is not available please provide a link to a website where readers can obtain access to data. 3. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript. 4. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Additional Editor Comments: Please respond to each point from both reviewers. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: I think the paper presents original research that has not been conducted in this setting and contributes to a growing body of research on the methods used to measure exclusive breastfeeding. However, some parts of the paper provided insufficient detail to assess the quality of the analysis. Furthermore, the conclusion is not supported by the data presented and I recommend this section be rewritten. Line by line comments below: Line 19: the EBF data collected using the 24-hour recall presented is a prevalence (i.e. a snapshot of the percent of infants who are exclusively breastfed at one point in time), not a rate. Suggest reframing throughout the paper as the "prevalence of exclusive breastfeeding". Lines 31-34: In the abstract, referring to the models as Model 1 and Model 2 is not sufficient for readers to understand the difference. Suggest clarifying that the difference between the two models is the cutoff that was used to determine EBF using the DTM. Lines 36-38: The conclusion to strengthen breastfeeding education does not flow logically from the data presented. For one, this is a recommendation, not a conclusion. The data presented suggests that there is a discrepancy between the DTM and the recall method, most likely due to overreporting. In my opinion, if a recommendation were to emerge from this finding, it would be related to improving the measurement of EBF or recommendations about interpreting 24 hour recall EBF data when using it for program monitoring and evaluation. Line 44-46: There is evidence that stunting that occurs before age 2 is potentially reversible under the right conditions. So I checked the reference cited here. This source does not seem to support the sentence. Please cite another source, or rewrite to align with the the data in this source. Line 47: Define EBF here. Line 49: Stunting is not a risk factor for poor child development per se, but a marker of poor child development (see LeRoy and Frongillo 2019). Lines 51-53: Since this manuscript is solely about EBF, suggest removing references to other IYCF monitoring. Lines 53-54: Since EBF here refers to the prevalence estimate, suggest revising to read "EBF prevalence among 0-6 month olds" to be more precise. Lines 68: The manuscript did not mention any policies in Eswatini nor how these findings could be used to inform or change policies. The data presented in this manuscript seems to assess the validity of EBF measured using the recall method; or to improve understanding of differences in EBF measurement by comparing recall and DTM. The purpose/goal of the study should be restated. Line 74: Please clarify whether this is the national prevalence of poverty or whether this is referring to rural poverty. It is unclear as stated. Also clarify whether the 54.8% refers to people or households. Lines71-79: Suggest moving to background section. Lines 102-130: This section combines the sample collection and processing with the analysis of the samples. If the editor agrees, suggest separating these two and describing the laboratory analysis of the saliva sample in the analysis section. Lines 134-135: The authors state that, "Model 2 was developed based on 24-hour observations of mothers practicing EBF." However, the study methods do not include observations, so this is confusing. I believe Model 2 only differs from Model 1 in that different cutoffs for NMOI were used to determine exclusive, predominant or partial BF. Also, please add a reference and clarify where the 86.6 cutoff came from. Lines 138-145: The description of the DTM sample collection and analysis is very detailed. However, there are few details about how the 24 hour recall data were collected. Where were mothers interviewed? When were they interviewed (at the beginning or at the end of the 14 day period)? How was EBF determined? Was it according to the WHO guidance, exactly? Authors state that the WHO recommended questionnaire was modified, but do not say how, which makes me wonder whether the analysis was modified as well. Lines 156-158: This needs a reference. Line 163: Please clarify what "up to high school education" means. Does this mean that 74.5% reported high school as the highest level of education completed? Does it mean 74.5% reported at least some high school education? Does this mean that 74.5% completed high school or less? Figure 1, Model 1: I am surprised to see that EBF was the same in the middle and older age group. I would have expected more of a difference. Have other studies had similar findings? Line 198: On line 156, the authors state that a score of -1.0 is "perfect disagreement" and that 0.21-0.40 [positive] represent fair agreement. So, I am confused that these negative kappa coefficients are described as "fair agreement" instead of fair disagreement. Please reconcile. Lines 213-216: This paragraph does not seem very relevant. Suggest deleting or revise to make the relevance to your findings more explicit. Lines 219-220: Do the methods allow you to distinguish between consumption of supplementary foods, other milks, beverages, and water? Could the non breast milk consumption be any of these things? I am not sure why it only mentions foods. Unless data from the survey suggests it is food and not water or other milks. Line 240: Social desirability bias likely results in the overestimation. However, it was difficult to assess how much it might have played a roll here. For example, the mother-infant dyads were recruited from health centers, so presumably all of them had been exposed to breastfeeding promotion messages. This may increase this bias. Other factors like who interviewed them and when are not mentioned, making it difficult to assess. Finally, were any steps taken to reduce social desirability bias? For example, introductory language before the questions, asking questions in different ways, etc. There is not enough detail in the methods section about how the questionnaire was administered to get a good grasp of this. Lines 243-252: It is worth mentioning that the 24 hour recall is just one day of the 14 observed using the DTM (assuming the interview occurred within the 14 day period, which is not stated in the methods). So complete agreement is not expected if mothers do not feed their infants in the same way every single day. It is also worth discussing how the 24 hour method is a proxy, not a direct measure, of EBF for the duration of the first six months as recommended by WHO, though it is often misinterpreted as such. Lines 254-260: The conclusions are not supported by the findings. Suggest rewriting this section completely. Reviewer #2: Thanks for the opportunity to review this paper, which compares EBF as reported using the WHO IYCF recall method and a stable isotope technique. It is helpful to have objective measures of EBF to better understand the reliability of the recall method. I think this is an important paper, but my overarching comment is about the framing. It’s not clear why this needs to be framed as important for child stunting. There are many other and more well documented reasons EBF is important for the health of infants. I would suggest framing the paper (in the intro and discussion) so that it focuses on the importance of accurate measurement of EBF and the potential influence of social desirability on survey responses. The discussion could talk more about what low agreement between the recall and isotope methods means for policy and practice. Countries are making policies based on the prevalence of EBF from Demographic and Health Surveys, Multiple Indicator Cluster Surveys, or SMART surveys. What should they do now, if the survey data on EBF are not accurate? In addition to my overarching comments, I would like to offer the following specific comments to the authors: Lines 44-45 – I suggest either removing the word “irreversible” or switching the order of “irreversible stunting” and “acute malnutrition.” The current order makes it seem like acute malnutrition is also irreversible, which is not true. Lines 48-50 – There is not much evidence that EBF is a protective factor against stunting. The Victora et al. paper cited does not show that EBF is related to stunting reduction. I suggest revising this sentence to highlight the documented benefits of EBF (as outlined in the Victora paper). Lines 50-52 – Please revise this sentence. IYCF indicators are not used to monitor malnutrition trends. Growth indicators (WHZ, HAZ, WAZ) are used for monitoring malnutrition trends. First paragraph of Background section – It’s not clear why the authors are emphasizing the connection between EBF and stunting in the first paragraph of the Background section. It seems like it would make sense to focus in this paragraph on the well-established benefits of EBF. Line 92 – How did you determine if the mothers were “clinically well”? Lines 139-140 – Please explain what kind of adaptations were made to the WHO IYCF questionnaire. Methods – Please include a sentence in the methods section stating that you collected data on the mothers’ socioeconomic characteristics. Please add a subsection on your sample size calculation and how you decided on the number of infants to include in each age group. In addition, it would be helpful to describe the sampling process. Was it purely convenience sampling or did you do stratified sampling by infant age? Table 1 – What do the numbers at the far-right side of the table represent? If they are not important, I would suggest removing them. Section starting on line 188 – Please add sentences to this section for the other two age groups. The text in this section currently only describes results for the youngest age group. Table 1 – I suggest using the same number of decimal places throughout the table. Two decimal places should be sufficient. Line 204 – Please be more specific with your statement here by including what the first study is about. Lines 209-210 – It’s not clear what issue related to measuring EBF the authors are referring to here. Please add more information about the issues mentioned. Lines 213-216 – It’s not clear how this is relevant to your main findings. Depending on the context, women with higher levels of education are less likely to EBF than women with lower levels. So, is your point that these women are not well enough educated or too well educated? Line 236 – I would suggest replacing “addressing child malnutrition” with “ensuring optimal infant feeding practices.” Line 241 – You may want to add a sentence about social desirability in the measurement of EBF in relation to this study by Christine Stewart et al., 2025: https://www.sciencedirect.com/science/article/pii/S247529912401713X Line 244-246 - This is the first time a stakeholder participatory approach is mentioned. If you are going to talk about this as a strength, please mention it in the methods section, although I don’t understand how a participatory approach is relevant as a strength in this case. Lines 255-256 – I suggest removing the sentence “Hence there is a need to strengthen breastfeeding education among mothers to reduce the rate of childhood malnutrition in Eswatini.” This conclusion does not follow from your results. In fact, it is likely that the breastfeeding education women are already receiving is contributing to the socially desirable responses they are giving on the WHO IYCF questionnaire. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 1 |
|
PONE-D-25-44019R1Validating self-reported exclusive breastfeeding in Eswatini using stable isotope techniquesPLOS One Dear Dr. Simelane, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Apr 22 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Jennifer Yourkavitch Academic Editor PLOS One Journal Requirements: 1. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: Thank you for your thorough and thoughtful responses to reviewers. There is one outstanding item--Reviewer 1, comment 21, states: "There is not enough detail in the methods section about how the questionnaire was administered to get a good grasp of this." Meaning of social desirability bias. You provided a thorough response to the reviewer but did not address this comment in the text. Since social desirability bias was named the major culprit for the discrepancy between recall and DTM, it's worth providing more explanation in the Methods section as you did in your response to reviewers. [Note: HTML markup is below. Please do not edit.] [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 2 |
|
Validating self-reported exclusive breastfeeding in Eswatini using stable isotope techniques PONE-D-25-44019R2 Dear Dr. Simelane, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Jennifer Yourkavitch Academic Editor PLOS One Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-25-44019R2 PLOS One Dear Dr. Simelane, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Jennifer Yourkavitch Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .